Executives
-
Van Plew Daniel PEVP & General Mgr, Industrial -
Stahl NeilEVP Research and Development
-
Pitofsky JasonVP Controller
-
Murphy Andrew JEVP Research
-
Mccourt MarionEVP Commercial
-
Larosa Joseph JEVP General Counsel and Secret
-
Fenimore Christopher R.SVP Finance & CFO
-
Schleifer Leonard SBd. Co-Chair, President & CEO
-
Yancopoulos GeorgeBd. Co-Chair, President & CSO
-
Landry Robert EEVP Finance CFO
?
Stahl Neil
EVP Research and Development
Regeneron Pharmaceuticals, Inc.
US, Tarrytown [HQ]
CIK
1226689
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
82,769
Price per Share :
$703.43
Equivalence :
$58,222,197.67
Transaction History
-
M82,769 Shares After TransactionValue : $33,079,458.54$12,289,545.00Transaction Date : 02/02/24
-
Footnotes
-
-
Footnotes:No footnote found.
-
F60,056 Shares After TransactionValue : $57,452,572.40$21,728,391.45Transaction Date : 02/02/24
-
Footnotes
-
-
Footnotes:No footnote found.
-
G50,999 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/26/24
-
Footnotes
-
-
Footnotes:No footnote found.
-
S56,096 Shares After TransactionValue : $60,686,335.68Sold $108,183.00Transaction Date : 08/08/24
-
Footnotes
-
-
Footnotes:#1 Represents volume-weighted average price of sales of 100 shares of Company stock on August 8, 2024 at prices ranging from $1,081.75 to $1,081.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.#2 Represents volume-weighted average price of sales of 200 shares of Company stock on August 8, 2024 at prices ranging from $1,082.65 to $1,082.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.#3 Represents volume-weighted average price of sales of 1,006 shares of Company stock on August 8, 2024 at prices ranging from $1,083.27 to $1,083.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.#4 Represents volume-weighted average price of sales of 1,883 shares of Company stock on August 8, 2024 at prices ranging from $1,084.01 to $1,084.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.#5 Represents volume-weighted average price of sales of 1,708 shares of Company stock on August 8, 2024 at prices ranging from $1,085.00 to $1,085.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.#6 Represents volume-weighted average price of sales of 300 shares of Company stock on August 8, 2024 at prices ranging from $1,086.14 to $1,086.16. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
-
S55,896 Shares After TransactionValue : $60,518,040.24Sold $216,538.00Transaction Date : 08/08/24
-
Footnotes
-
-
Footnotes:#1 Represents volume-weighted average price of sales of 100 shares of Company stock on August 8, 2024 at prices ranging from $1,081.75 to $1,081.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.#2 Represents volume-weighted average price of sales of 200 shares of Company stock on August 8, 2024 at prices ranging from $1,082.65 to $1,082.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.#3 Represents volume-weighted average price of sales of 1,006 shares of Company stock on August 8, 2024 at prices ranging from $1,083.27 to $1,083.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.#4 Represents volume-weighted average price of sales of 1,883 shares of Company stock on August 8, 2024 at prices ranging from $1,084.01 to $1,084.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.#5 Represents volume-weighted average price of sales of 1,708 shares of Company stock on August 8, 2024 at prices ranging from $1,085.00 to $1,085.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.#6 Represents volume-weighted average price of sales of 300 shares of Company stock on August 8, 2024 at prices ranging from $1,086.14 to $1,086.16. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.